Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsCVS Caremark Non-Covered Drug Prior Auth | OpenPay…
    Ask Trek AI about this page
    CurrentCVS CaremarkPolicy 717-A

    Non-covered Drug Medical Necessity

    Customize your policy alerts

    Sign up for cvs_caremark Policy 717-A alerts

    Get alerted when Policy 717-A changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization for requested drugs classified as non-covered under CVS Caremark medical necessity criteria. Coverage may be authorized when the patient cannot use formulary alternatives, the requested use is supported by FDA labeling or accepted compendia, and the dose and quantity are appropriate.

    Policy Summary
    PayerCVS Caremark
    PolicyNon-covered Drug Medical Necessity
    Policy CodePolicy 717-A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the patient's inadequate response, intolerance, or contraindication to the required formulary alternatives.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4Required coverage criteria
    12 monthsApproval duration
    FDA or compendiaIndication support

    Non-Covered Drug Medical Necessity

    Non-covered drug medical necessity

    Policy Summary
    PayerCVS Caremark
    PolicyNon-covered Drug Medical Necessity
    Policy CodePolicy 717-A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument the patient's inadequate response, intolerance, or contraindication to the required formulary alternatives.
    SourceLink
    On This Page
    Non-Covered Drug Medical NecessityAuthorization and Documentation RequirementsPolicy BackgroundInitial Medical Necessity AuthorizationFormulary Alternative Requirement

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Authorization may be granted when ALL of the following criteria are met.

    Medical necessity requirements

    • Formulary alternative requirement: The patient cannot be treated with a formulary drug.
    • Inability to use formulary alternatives: The patient is unable to take the required number of formulary alternatives for the given diagnosis due to a trial and inadequate treatment response or intolerance, or a contraindication.

      Documentation is required for approval.

    • Supported indication: The requested drug is being used for an FDA-approved indication or an indication supported in the compendia of current literature, including AHFS, Micromedex, or current accepted guidelines.
    • Appropriate dose and quantity: The prescribed dose and quantity fall within FDA-approved labeling or within dosing guidelines found in the compendia of current literature.

    Authorization and Documentation Requirements

    Prior Authorization

    Medical Necessity Authorization

    Prior authorization may be granted only when all stated medical-necessity criteria for the requested drug are met and the provider submits the required supporting information.

    Step Therapy

    Required Formulary Alternative Trials

    The patient must be unable to take the required number of formulary alternatives for the diagnosis because of a documented trial with inadequate treatment response or intolerance, or because of a contraindication.

    • Required formulary alternative trials must be completed unless the alternatives are contraindicated or cannot be tolerated.
    Documentation Required

    Document Formulary Alternative History

    Submit documentation showing the patient’s history with formulary alternatives, including treatment response, intolerance, or the specific contraindication preventing use.

    • Approval requires documentation of inadequate treatment response or intolerance, or a contraindication to the required formulary alternatives.
    Denial Risk

    Formulary Alternatives Available

    The requested drug must be necessary because the patient cannot be treated with a formulary drug. Authorization may be denied when a formulary drug remains suitable or when the required alternative trials are incomplete without a documented exception.

    Denial Risk

    Unsupported Indication

    The requested drug must be used for an FDA-approved indication or for an indication supported by current compendia of the literature, such as AHFS, Micromedex, or current accepted guidelines. Unsupported uses may be denied.

    Denial Risk

    Dose or Quantity Outside Guidelines

    The prescribed dose and quantity must fall within FDA-approved labeling or dosing guidelines in current compendia of the literature. Requests outside these parameters may be denied.

    Policy Background

    This policy establishes the medical necessity framework for requested drugs that are not covered through the formulary pathway. Coverage may be authorized when the patient cannot be treated with formulary alternatives, the requested use is supported by an FDA-approved indication or current literature compendia, and the prescribed dose and quantity remain within applicable labeling or dosing guidelines.

    Initial Medical Necessity Authorization

    Initial medical necessity authorization

    Initial authorization may be granted when ALL of the following criteria are met.

    Initial authorization requirements

    • Formulary alternative requirement: The patient cannot be treated with a formulary drug.
    • Alternative failure, intolerance, or contraindication: The patient is unable to take the required number of formulary alternatives for the given diagnosis due to a trial and inadequate treatment response or intolerance, or a contraindication.

      Documentation is required for approval.

    • Indication support: The requested drug is being used for an FDA-approved indication or an indication supported by current literature compendia.
    • Dose and quantity: The prescribed dose and quantity fall within FDA-approved labeling or applicable compendia dosing guidelines.

    Formulary Alternative Requirement

    StepRequirementFailure criteria
    1The patient cannot be treated with a formulary drug and must be unable to take the required number of formulary alternatives for the given diagnosis.Trial with inadequate treatment response, intolerance, or a contraindication to the required number of formulary alternatives.